ASSESSMENT OF CYTO/GENOTOXICITY OF IRINOTECAN IN V79 CELLS USING THE COMET, MICRONUCLEUS, AND CHROMOSOME ABERRATION ASSAY

被引：8

作者：

Kasuba, Vilena ^{[1
]}

Rozgaj, Ruzica

Gamulin, Marija ^{[2
]}

Trosic, Ivancica

机构：

[1] Univ Zagreb, Clin Hosp Ctr Zagreb, Mutagenesis Unit, Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia

[2] Univ Zagreb, Oncol Clin, Zagreb, Croatia

来源：

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY | 2010年 / 61卷 / 01期

关键词：

alkaline comet assay; antineoplastic drug; cell cultures; DNA and cytogenetic damage; topoisomerase; DNA TOPOISOMERASE-I; INTESTINAL DAMAGE; ANTICANCER DRUGS; BREAST-CANCER; STRAND-BREAKS; BLOOD-CELLS; BONE-MARROW; CAMPTOTHECIN; APOPTOSIS; VITRO;

D O I：

10.2478/10004-1254-61-2010-1967

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Irinotecan is a topoisomerase I interactive agent, widely used in the treatment of metastatic colorectal cancer. The genotoxic effects of the maximum single dose (18 mu g mL(-1)), recommended monotherapy dose (9 mu g mL(-1)), and recommended combined therapy dose (4.5 mu g mL(-1)) of irinotecan were studied on V79 cells using the comet assay, chromosome aberration assay, and micronucleus test. The cells were treated with irinotecan for 2 h or 24 h. The statistical significance of the results was determined using the one-way ANOVA test and a nonparametric Mann Whitney U test. The comet assay did not show dose-dependent or time-dependent effects. The chromosome aberration analysis showed large DNA rearrangements, i.e., chromosome exchanges. Although the exposed cultures showed a significant increase in micronucleated cells in respect to control, no dose-dependent relation was established among the treated cultures. Time-dependent effect was also not observed.

引用

页码：1 / 9

页数：9

共 34 条

[11] Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer [J].

Gibson, RJ ;

Bowen, JM ;

Inglis, MRB ;

Cummins, AG ;

Keefe, DMK .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) :1095-1100

[12] Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay [J].

Godard, T ;

Deslandes, E ;

Sichel, F ;

Poul, JM ;

Gauduchon, P .

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2002, 520 (1-2) :47-56

[13]

Gradzka I, 1998, CELL BIOCHEM FUNCT, V16, P239

[14] Combination of oxaliplatin and irinotecan on human colon cancer cell lines:: activity in vitro and in vivo [J].

Guichard, S ;

Arnould, S ;

Hennebelle, I ;

Bugat, R ;

Canal, P .

ANTI-CANCER DRUGS, 2001, 12 (09) :741-751

[15] Consumption of an omega-3 fatty acids product, INCELL AAFA™, reduced side-effects of CPT-11 (irinotecan) in mice [J].

Hardman, WE ;

Moyer, MP ;

Cameron, IL .

BRITISH JOURNAL OF CANCER, 2002, 86 (06) :983-988

[16] ON THE MECHANISM OF TOPOISOMERASE-I INHIBITION BY CAMPTOTHECIN - EVIDENCE FOR BINDING TO AN ENZYME DNA COMPLEX [J].

HERTZBERG, RP ;

CARANFA, MJ ;

HECHT, SM .

BIOCHEMISTRY, 1989, 28 (11) :4629-4638

[17] MICRONUCLEUS INDUCTION BY CAMPTOTHECIN AND AMSACRINE IN BONE-MARROW OF MALE AND FEMALE CD-1 MICE [J].

HOLMSTROM, M ;

WINTERS, V .

MUTAGENESIS, 1992, 7 (03) :189-193

[18]

Houghton PJ, 1998, ONCOLOGY-NY, V12, P84

[19]

HSIANG YH, 1988, CANCER RES, V48, P1722

[20]

HSIANG YH, 1985, J BIOL CHEM, V260, P4873

← 1 2 3 4 →